Treatment of mandibular malignant fibrous histiocytoma during pregnancy

Journal of Oral and Maxillofacial Surgery

Volumn 59, Issue 2, 2001, Pages 220-224

  Otsuka, K ^a   Hamakawa, H ^a   Sumida, T ^a   Tanioka, H ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA; TITANIUM;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL EXAMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMPLANT; MALIGNANT FIBROUS HISTIOCYTOMA; MANDIBLE CANCER; MANDIBLE RECONSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANORAMIC RADIOGRAPHY; PREGNANCY; TUMOR BIOPSY;

EID: 0035129201     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1053/joms.2001.20505     Document Type: Article

References (30)

1. Malignant fibrous histiocytoma: An analysis of 200 cases
2. Fetal prognosis after anesthesia during gestation
3. Maternal and fetal hazards of surgery during pregnancy
4. Surgery during pregnancy and fetal outcome
5. Anesthesia and surgery during pregnancy
6. Influence of certain drugs on the prenatal development
7. Teratology in anesthesia
8. Malignant fibrous histiocytoma of soft tissue: A population-based epidemiologic and prognostic study of 137 patients
9. Prognostic factors in 227 patients with malignant fibrous histiocytoma
10. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis
11. Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy
12. Acute leukemia in pregnancy: Successful delivery after cytarabine and doxorubicin
13. Acute leukemia during pregnancy: The Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents
14. Pregnancy outcome in survivors of advanced Hodgkin disease
15. Chemotherapy of sarcomas
16. Reduction of ifosfamide toxicity using dose fractionation
17. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas
18. High-dose methotrexate as secondary chemotherapy in metastatic soft-tissue sarcomas
19. A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people
20. Cisplatin: A phase II evaluation in previously untreated patients with soft tissue sarcomas
21. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: The M. D. Anderson experience
22. Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination
23. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy
24. Ifosfamide in pediatric malignant solid tumors
25. Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
26. Response to ifosfamide and mesna: 124 Previously treated patients with metastatic or unresectable sarcoma
27. A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people
28. Synovial sarcoma: Uniform response of metastases to high dose ifosfamide
29. A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas
30. Malignant fibrous histiocytoma of soft tissue: An analysis of 78 cases located and deeply seated in the extremities